Team approach boosts weight loss in fatty liver disease
NCT ID NCT07366463
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a team-based approach for people with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), a type of fatty liver linked to heart problems. 286 adults received either standard care or extra support from a liver doctor, a nutritionist, and a psychologist. The goal was to help them lose at least 10% of their body weight and keep it off for 18 months, which can improve liver health and lower heart risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR EVENTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Campania Luigi Vanvitelli
Naples, Campania, 80138, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hidden liver risk in type 1 diabetes: a new study investigates
- Flu vaccine showdown: which shot protects seniors best?
- Heart scans could flag Who's at risk after liver shunt
- Could a common b vitamin tame fatty liver?
- Could a daily dose of citrus fiber tame fatty liver inflammation?
- Could a simple cooking tweak reverse fatty liver? a new trial puts low-AGE foods to the test.